Impact of folic acid fortification in the United States: Markedly diminished high maternal serum alpha-fetoprotein values

Mark I. Evans, Elisa Llurba, Ellen J. Landsberger, Joseph E. O'Brien, Harold H. Harrison

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

OBJECTIVE: Folic acid fortification of breads and grains was implemented in the United States in 1998 in an attempt to reduce the incidence of neural tube defects. Outcome data from birth registries have shown a 20% drop-less than originally predicted. In this study, we ascertain if the impact of folic acid fortification is better seen at the time of midtrimester prenatal diagnosis by looking at incidence of high maternal serum alpha-fetoprotein (MSAFP) values. METHODS: Data regarding MSAFP levels in 61,119 patients undergoing maternal serum screening at a large commercial laboratory were categorized by multiples of the median (MoM). The data were compared between 2 groups: before mandatory supplementation in the United States in 1997 and after mandatory supplementation in 2000. High MSAFP values were further categorized as high (2.75-4.00 MoM) or very high (more than 4.00 MoM). Data were analyzed by χ2 analysis. RESULTS: Comparative data showed a 32% decrease of patients with MoM greater than 2.75 + (2.5% -1.7%). Further categorizations revealed similar decreases. CONCLUSION: The introduction of folic acid fortification has produced a profound decrease in the number of high MSAFP values, reflective of a decreased incidence of neural tube defects. Our results help to validate the decision to fortify food with folic acid, which represents a highly successful public health policy for primary prevention of birth defects.

Original languageEnglish (US)
Pages (from-to)474-479
Number of pages6
JournalObstetrics and Gynecology
Volume103
Issue number3
DOIs
StatePublished - Mar 2004
Externally publishedYes

Fingerprint

alpha-Fetoproteins
Folic Acid
Mothers
Serum
Neural Tube Defects
Incidence
Bread
Second Pregnancy Trimester
Primary Prevention
Public Policy
Health Policy
Prenatal Diagnosis
Registries
Public Health
Parturition
Food

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Impact of folic acid fortification in the United States : Markedly diminished high maternal serum alpha-fetoprotein values. / Evans, Mark I.; Llurba, Elisa; Landsberger, Ellen J.; O'Brien, Joseph E.; Harrison, Harold H.

In: Obstetrics and Gynecology, Vol. 103, No. 3, 03.2004, p. 474-479.

Research output: Contribution to journalArticle

Evans, Mark I. ; Llurba, Elisa ; Landsberger, Ellen J. ; O'Brien, Joseph E. ; Harrison, Harold H. / Impact of folic acid fortification in the United States : Markedly diminished high maternal serum alpha-fetoprotein values. In: Obstetrics and Gynecology. 2004 ; Vol. 103, No. 3. pp. 474-479.
@article{6f6a76f69dee4aaa9d2a64b412b4b7bd,
title = "Impact of folic acid fortification in the United States: Markedly diminished high maternal serum alpha-fetoprotein values",
abstract = "OBJECTIVE: Folic acid fortification of breads and grains was implemented in the United States in 1998 in an attempt to reduce the incidence of neural tube defects. Outcome data from birth registries have shown a 20{\%} drop-less than originally predicted. In this study, we ascertain if the impact of folic acid fortification is better seen at the time of midtrimester prenatal diagnosis by looking at incidence of high maternal serum alpha-fetoprotein (MSAFP) values. METHODS: Data regarding MSAFP levels in 61,119 patients undergoing maternal serum screening at a large commercial laboratory were categorized by multiples of the median (MoM). The data were compared between 2 groups: before mandatory supplementation in the United States in 1997 and after mandatory supplementation in 2000. High MSAFP values were further categorized as high (2.75-4.00 MoM) or very high (more than 4.00 MoM). Data were analyzed by χ2 analysis. RESULTS: Comparative data showed a 32{\%} decrease of patients with MoM greater than 2.75 + (2.5{\%} -1.7{\%}). Further categorizations revealed similar decreases. CONCLUSION: The introduction of folic acid fortification has produced a profound decrease in the number of high MSAFP values, reflective of a decreased incidence of neural tube defects. Our results help to validate the decision to fortify food with folic acid, which represents a highly successful public health policy for primary prevention of birth defects.",
author = "Evans, {Mark I.} and Elisa Llurba and Landsberger, {Ellen J.} and O'Brien, {Joseph E.} and Harrison, {Harold H.}",
year = "2004",
month = "3",
doi = "10.1097/01.AOG.0000114984.82549.99",
language = "English (US)",
volume = "103",
pages = "474--479",
journal = "Obstetrics and Gynecology",
issn = "0029-7844",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Impact of folic acid fortification in the United States

T2 - Markedly diminished high maternal serum alpha-fetoprotein values

AU - Evans, Mark I.

AU - Llurba, Elisa

AU - Landsberger, Ellen J.

AU - O'Brien, Joseph E.

AU - Harrison, Harold H.

PY - 2004/3

Y1 - 2004/3

N2 - OBJECTIVE: Folic acid fortification of breads and grains was implemented in the United States in 1998 in an attempt to reduce the incidence of neural tube defects. Outcome data from birth registries have shown a 20% drop-less than originally predicted. In this study, we ascertain if the impact of folic acid fortification is better seen at the time of midtrimester prenatal diagnosis by looking at incidence of high maternal serum alpha-fetoprotein (MSAFP) values. METHODS: Data regarding MSAFP levels in 61,119 patients undergoing maternal serum screening at a large commercial laboratory were categorized by multiples of the median (MoM). The data were compared between 2 groups: before mandatory supplementation in the United States in 1997 and after mandatory supplementation in 2000. High MSAFP values were further categorized as high (2.75-4.00 MoM) or very high (more than 4.00 MoM). Data were analyzed by χ2 analysis. RESULTS: Comparative data showed a 32% decrease of patients with MoM greater than 2.75 + (2.5% -1.7%). Further categorizations revealed similar decreases. CONCLUSION: The introduction of folic acid fortification has produced a profound decrease in the number of high MSAFP values, reflective of a decreased incidence of neural tube defects. Our results help to validate the decision to fortify food with folic acid, which represents a highly successful public health policy for primary prevention of birth defects.

AB - OBJECTIVE: Folic acid fortification of breads and grains was implemented in the United States in 1998 in an attempt to reduce the incidence of neural tube defects. Outcome data from birth registries have shown a 20% drop-less than originally predicted. In this study, we ascertain if the impact of folic acid fortification is better seen at the time of midtrimester prenatal diagnosis by looking at incidence of high maternal serum alpha-fetoprotein (MSAFP) values. METHODS: Data regarding MSAFP levels in 61,119 patients undergoing maternal serum screening at a large commercial laboratory were categorized by multiples of the median (MoM). The data were compared between 2 groups: before mandatory supplementation in the United States in 1997 and after mandatory supplementation in 2000. High MSAFP values were further categorized as high (2.75-4.00 MoM) or very high (more than 4.00 MoM). Data were analyzed by χ2 analysis. RESULTS: Comparative data showed a 32% decrease of patients with MoM greater than 2.75 + (2.5% -1.7%). Further categorizations revealed similar decreases. CONCLUSION: The introduction of folic acid fortification has produced a profound decrease in the number of high MSAFP values, reflective of a decreased incidence of neural tube defects. Our results help to validate the decision to fortify food with folic acid, which represents a highly successful public health policy for primary prevention of birth defects.

UR - http://www.scopus.com/inward/record.url?scp=1842563113&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1842563113&partnerID=8YFLogxK

U2 - 10.1097/01.AOG.0000114984.82549.99

DO - 10.1097/01.AOG.0000114984.82549.99

M3 - Article

C2 - 14990409

AN - SCOPUS:1842563113

VL - 103

SP - 474

EP - 479

JO - Obstetrics and Gynecology

JF - Obstetrics and Gynecology

SN - 0029-7844

IS - 3

ER -